Blend compositions for oral administration as a rapidly dissolving powder and/or suspension

A free flowing dry powder oral formulation suitable for administration in each of an aqueous solution, aqueous dispersion, tablet, and powder dosage form,

• wherein the formulation comprises an active pharmaceutical ingredient (API) in an amount from about 3% w/w to about 15% w/w, a galactomannan in an amount from about 0.05% w/w to about 0.5% w/w, one or more sweetening agents in an amount up to about 90% w/w, two or more flavoring agents in an amount from about 0.5% w/w to about 5% w/w and an organic acid in an amount from about 0.05% w/w to about 0.5% w/w, in a pharmaceutically acceptable preparation.

A free flowing dry powder oral formulation suitable for administration in each of an aqueous solution, aqueous dispersion, tablet, and powder dosage form,

• wherein the formulation comprises a non-steroidal anti-inflammatory drug (NSAID) in an amount from about 6% w/w to about 10% w/w, a galactomannan in an amount from about 0.2% w/w to about 0.4% w/w, one or more sweetening agents in an amount up to about 90% w/w, one or more flavoring agents in an amount from about 0.5% w/w to about 5% w/w and an organic acid in an amount from about 0.1% w/w to about 0.2% w/w, in a pharmaceutically acceptable preparation.